Detalhe da pesquisa
1.
PegIFNα/ribavirin/protease inhibitor combination in severe hepatitis C virus-associated mixed cryoglobulinemia vasculitis.
J Hepatol
; 62(1): 24-30, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25135864
2.
INF2 mutations in Charcot-Marie-Tooth disease with glomerulopathy.
N Engl J Med
; 365(25): 2377-88, 2011 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-22187985
3.
Rituximab plus Peg-interferon-alpha/ribavirin compared with Peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemia.
Blood
; 116(3): 326-34; quiz 504-5, 2010 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-20439619
4.
Identification of human herpesvirus 6 variants A and B by primer-specific real-time PCR may help to revisit their respective role in pathology.
J Clin Virol
; 35(3): 257-63, 2006 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-16183328
5.
Efficacy and tolerability of rituximab with or without PEGylated interferon alfa-2b plus ribavirin in severe hepatitis C virus-related vasculitis: a long-term followup study of thirty-two patients.
Arthritis Rheum
; 60(8): 2531-40, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19644879